Company Insight – Page 23 – media

Microsoft and Adaptive Biotech to create universal blood test using AI

Microsoft has partnered with and invested in US-based Adaptive Biotechnologies to map the human immune system genetics using artificial intelligence (AI) for early detection and diagnosis of multiple diseases, including cancer.
- Source: Verdict Medical Devices
- 530
- January 8, 2018
AI Company Insight Microsoft
FDA approves Mevion’s Hyperscan pencil beam scanning technology

Mevion S250i is a compact proton therapy system that has the capacity to deliver conformal radiation therapy treatments with the support of Hyperscan pencil beam scanning technology.
- Source: MDBR
- 555
- January 8, 2018
Company Insight FDA medical device
BioNTech raises $270M A round to fuel mRNA, CAR-T R&D

BioNTech has raised $270 million (€224 million). The series A round positions the German biotech to mount a multifront attack on cancer, spearheaded by mRNA therapies and supported by a clutch of other modalities including CAR-T cells.
- Source: fiercebiotech
- 649
- January 5, 2018
CAR-T therapy Company Insight mRNA Series
Sangamo partners with Pfizer to develop gene therapy for ALS

Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS
- Source: Reuters
- 507
- January 4, 2018
ALS Company Insight FDA Gene therapy Pfizer
Scholar Rock scoops $47M to trial SMA drug

Scholar Rock has raised $47 million to take its treatment for spinal muscular atrophy (SMA) into the clinic. The series C tees up Scholar Rock to find out whether its myostatin blocker can best the underwhelming performance of one-time rivals from companies including Novartis.
- Source: fiercebiotech
- 499
- January 4, 2018
blocker Company Insight myostatin SMA
In boost to Abbott, spinal-cord implants emerge as alternative to pills

Recent innovations from global device makers like Abbott to smaller specialists such as Nevro Corp. made the implants more powerful and effective. Combined with a national crackdown on narcotics and wanton pain pill prescriptions, they are spurring demand for implants.
- Source: Crain's Chicago Business
- 572
- January 4, 2018
Abbott Company Insight healthcare technology medtech nerve cell opioid
Scientists Unveil the First Portable Bionic Hand With a Sense of Touch

The first portable bionic hand restores the sense of touch in people who lost their limbs. Although the hand is still a prototype, we're one step closer to the day when a fully natural, sensorized prosthesis will be available.
- Source: Futurism
- 442
- January 4, 2018
Company Insight digital health healthcare technology medtech
Roche snags another Perjeta combo nod, but will ‘weak’ data limit its use?

Analysts and investors think Perjeta’s end-of-the-year indication may not be as lucrative as they once hoped. The FDA green-lighted the drug in tandem with giant Herceptin and chemo for HER2-positive, post-surgery breast cancer patients with a high risk of recurrence. Patients should receive up to 18 cycles of the regimen over the course of one year, according to the indication.
- Source: fiercepharma
- 566
- December 28, 2017
breast cancer Company Insight FDA HER2-positive
Mallinckrodt inks $1.2B Sucampo buy, ending rough 2017 on a high note

Mallinckrodt, which has landed in hot water multiple times this year, is diversifying beyond its controversial lead seller.
- Source: fiercepharma
- 445
- December 28, 2017
chronic Company Insight constipation Market Views
Janssen buys into Legend’s CART therapy

Janssen has entered into a global collaboration and license agreement with Legend Biotech USA and Legend Biotech Ireland to develop, manufacture and commercialise experimental CART-cell therapy LCAR-B38M.
- Source: Pharmatimes
- 421
- December 26, 2017
CAR-T therapy Company Insight Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.